Dilated cardiomyopathy and coagulation factor VIII deficiency as a rare genetic combination

Genetic dilated cardiomyopathy and hemophilia are two distinct diseases. Mutations in various genes, including TTN, LMNA, and other coding proteins, play a central role in the pathogenesis of dilated cardiomyopathy. On the other hand, hemophilia is a genetically determined blood clotting disorder in which the main role is assigned to the deficiency of factors VIII or IX (hemophilia A and B). Therefore, the diagnosis and management of both diseases largely depend on genetic screening and molecular studies. The simultaneous occurrence of dilated cardiomyopathy (DCM) and hemophilia is extremely rare. Our clinical case reviews the genetic characteristics, associated complications, diagnostic approaches, clinical significance, and therapeutic strategies of both conditions.

Authors

Institutions

Publication Details

Journal
Health Policy Economics and Sociology
Published
2025-07-26
DOI
https://doi.org/10.52340/healthecosoc.2025.09.02.06
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dilated cardiomyopathy and coagulation factor VIII deficiency as a rare genetic combination

Mariam Lomidze, Nata Kazakhashvili, Sophio Ungiadze, Tamaz Kheladze et al.
Health Policy Economics and Sociology
Hemophilia Treatment and Research
article

Dilated cardiomyopathy and coagulation factor VIII deficiency as a rare genetic combination

Mariam Lomidze, Nata Kazakhashvili, Sophio Ungiadze, Tamaz Kheladze, Giorgi Bazerashvili, Sophio Tskhvedadze
article en

Abstract

Genetic dilated cardiomyopathy and hemophilia are two distinct diseases. Mutations in various genes, including TTN, LMNA, and other coding proteins, play a central role in the pathogenesis of dilated cardiomyopathy. On the other hand, hemophilia is a genetically determined blood clotting disorder in which the main role is assigned to the deficiency of factors VIII or IX (hemophilia A and B). Therefore, the diagnosis and management of both diseases largely depend on genetic screening and molecular studies. The simultaneous occurrence of dilated cardiomyopathy (DCM) and hemophilia is extremely rare. Our clinical case reviews the genetic characteristics, associated complications, diagnostic approaches, clinical significance, and therapeutic strategies of both conditions.

Health Policy Economics and Sociology
Tbilisi State University (GE)
Zero hunger
Openalex Percentile: Top 77%
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.